PRECISION BIOSCIENCES

View On IC.GC.CA

ADVERTISED

on 24 Jan 2025

Last Applicant/ Owned by

Precision BioSciences, Inc.

302 East Pettigrew Street,Dibrell Warehouse, Suite A-100Durham NC 27701-3712

Serial Number

2192464 filed on 18^th Nov 2021

Registration Number

TMA1286158 registered on 24^th Jan 2025

Registration expiry Date

18^th Nov 2031

Correspondent Address

CPST INTELLECTUAL PROPERTY INC.

130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

M5A0P6

PRECISION BIOSCIENCES

Trademark usage description

genome editing reagents for research purposes; chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture, name Read More

Vienna Information

1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cells, images of bacteria or viruses, DNA helixesSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales, images de bactéries ou de virus, hélices d'ADN

9 . 1 . 10

Ribbons, bowsRubans, noeuds

26 . 1 . 1

CirclesCercles

26 . 1 . 4

Two circles, two ellipses, one inside the otherDeux cercles, deux ellipses, l'un dans l'autre

26 . 1 . 12

Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).

26 . 1 . 13

Circles or ellipses containing representations of heavenly bodies or natural phenomenaCercles ou ellipses contenant la représentation de corps célestes ou de phénomènes naturels

26 . 1 . 16

Circles or ellipses containing other figurative elementsCercles ou ellipses contenant d'autres éléments figuratifs

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 11

Broken lines or bands (except a 26.11.13)Lignes ou bandes brisées (excepté a 26.11.13)

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

Classification Information

Class [001]
Genome editing reagents for research purposes; chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors; chemical, biochemical, biotechnological and bacteriological products intended for research laboratories and control laboratories, namely polypeptides for in vivo and in vitro genetic engineering; biochemicals and biologics, namely, engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, pharmaceutical research, agricultural biotechnology, diagnostics, and industrial biotechnology; engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research and analysis and diagnostics.

Classification kind code

Class [005]
Pharmaceutical preparations, namely, cell therapy products utilizing T-cell therapy for use in treating disease; pharmaceuticals for the treatment of cancer; pharmaceutical preparations in the nature of genetically modified cells, namely genetically modified immune cells for use in human therapeutics and in the treatment of cancer; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications, namely, antifungal preparations, dermatological preparations for the treatment of genetic conditions, namely, cancer, smoking cessation preparations and tissue repair preparations; engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use.

Classification kind code

Class [042]
Research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic disease, gene therapy and cell therapy; pharmaceutical research and development services; scientific research in genetic, medical, pharmaceutical, and veterinary fields; scientific research for medical purposes in the field of cancerous diseases; scientific analysis in the field of immunotherapy; scientific research in the field of cellular immunotherapy utilizing chimeric antigen receptor t cells for use in treating cancer; scientific research in genetic, medical, pharmaceutical and veterinary fields; scientific research in chemistry, biology, biochemistry, molecular biology, bacteriology.

Classification kind code

Class [044]
Medical services, namely, cellular immunotherapy programs utilizing chimeric antigen receptor t cells for use in treating disease, namely, the treatment of cancer; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer.

Classification kind code

Mark Details

Serial Number

2192464

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 22^nd Mar 2024	Agent Changed
Submitted for opposition 22 on 29^th Sept 2023	Search Recorded
Submitted for opposition 20 on 29^th Sept 2023	Examiner's First Report
Submitted for opposition 223 on 29^th Sept 2023	Total Provisional Refusal
Submitted for opposition 256 on 17^th Apr 2023	Notification of Possible Opposition Sent
Submitted for opposition 1 on 20^th Jun 2022	Created
Submitted for opposition 31 on 20^th Jun 2022	Formalized
Submitted for opposition 257 on 16^th Jun 2022	Designation Notification - Madrid Protocol
Submitted for opposition 228 on 18^th Nov 2021	International Registration
Submitted for opposition 30 on 18^th Nov 2021	Filed